Lorazepam Tablet
NDC Package 72789-357-95
Package Information
Lorazepam tablets is a medication used to treat anxiety. This formulation utilizes a tablet delivery system. Marketed by Pd-rx Pharmaceuticals, Inc., this product is identified by NDC 72789-357 and is authorized under FDA application ANDA076045.
Identification & Billing
- RxCUI: 197900 - LORazepam 0.5 MG Oral Tablet
- RxCUI: 197900 - lorazepam 0.5 MG Oral Tablet
- RxCUI: 197901 - LORazepam 1 MG Oral Tablet
- RxCUI: 197901 - lorazepam 1 MG Oral Tablet
- RxCUI: 197902 - LORazepam 2 MG Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 72789 - Pd-rx Pharmaceuticals, Inc.
- 72789-357 - Lorazepam
- 72789-357-95 - 1000 TABLET in 1 BOTTLE, PLASTIC
- 72789-357 - Lorazepam
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (72789-357). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 72789-357-95 identifies a specific commercial package of 1000 tablet in 1 bottle, plastic of Lorazepam, a human prescription drug labeled by Pd-rx Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1000 billable units per package. This tablet is formulated for oral use and contains lorazepam as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pd-rx Pharmaceuticals, Inc. on October 26, 2023. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used to treat anxiety. Lorazepam belongs to a class of drugs known as benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. This drug works by enhancing the effects of a certain natural chemical in the body (GABA).
How is this Pd-rx Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 72789035795. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1000 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.